NATERA, INC. Payments of Debt Issuance Costs
NATERA, INC. (NTRA) reported Payments of Debt Issuance Costs of $287.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2020-03-02
- NATERA, INC. payments of debt issuance costs for the quarter ending 2015-12-31 was $0.00.
- NATERA, INC. payments of debt issuance costs for the quarter ending 2015-09-30 was $0.00.
- NATERA, INC. payments of debt issuance costs for the quarter ending 2015-06-30 was $0.00.
- NATERA, INC. payments of debt issuance costs for the quarter ending 2015-03-31 was $6.00K.
- NATERA, INC. payments of debt issuance costs for fiscal 2017 was $287.00K.
- NATERA, INC. payments of debt issuance costs for fiscal 2015 was $6.00K.
- NATERA, INC. payments of debt issuance costs for fiscal 2013 was $479.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2017-12-31 | $287.00K 10-K · filed 2020-03-02 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $6.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $6.00K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $6.00K 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $6.00K 10-Q · filed 2016-05-13 | |||
| 2013-12-31 | $479.00K 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |